337 related articles for article (PubMed ID: 23295386)
1. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
[TBL] [Abstract][Full Text] [Related]
2. Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes.
Kandel BA; Thomas M; Winter S; Damm G; Seehofer D; Burk O; Schwab M; Zanger UM
Biochim Biophys Acta; 2016 Sep; 1859(9):1218-1227. PubMed ID: 26994748
[TBL] [Abstract][Full Text] [Related]
3. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.
Pan DA; Mater MK; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Lipid Res; 2000 May; 41(5):742-51. PubMed ID: 10787435
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8.
Thomas M; Winter S; Klumpp B; Turpeinen M; Klein K; Schwab M; Zanger UM
Front Pharmacol; 2015; 6():261. PubMed ID: 26582990
[TBL] [Abstract][Full Text] [Related]
5. CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver.
Makia NL; Goldstein JA
Mol Pharmacol; 2016 Jan; 89(1):154-64. PubMed ID: 26467040
[TBL] [Abstract][Full Text] [Related]
6. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
[TBL] [Abstract][Full Text] [Related]
7. Hepatic hypoxia-inducible factors inhibit PPARα expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity.
Li D; Du Y; Yuan X; Han X; Dong Z; Chen X; Wu H; Zhang J; Xu L; Han C; Zhang M; Xia Q
Free Radic Biol Med; 2017 Sep; 110():102-116. PubMed ID: 28583670
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha.
Shin M; Kim I; Inoue Y; Kimura S; Gonzalez FJ
Mol Pharmacol; 2006 Oct; 70(4):1281-90. PubMed ID: 16807375
[TBL] [Abstract][Full Text] [Related]
10. Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.
Gopinathan L; Hannon DB; Peters JM; Vanden Heuvel JP
Toxicol Sci; 2009 Mar; 108(1):48-58. PubMed ID: 19103650
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites.
Sérée E; Villard PH; Pascussi JM; Pineau T; Maurel P; Nguyen QB; Fallone F; Martin PM; Champion S; Lacarelle B; Savouret JF; Barra Y
Gastroenterology; 2004 Nov; 127(5):1436-45. PubMed ID: 15521013
[TBL] [Abstract][Full Text] [Related]
12. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
[TBL] [Abstract][Full Text] [Related]
13. Effects of 4-nonylphenol on hepatic gene expression of peroxisome proliferator-activated receptors and cytochrome P450 isoforms (CYP1A1 and CYP3A4) in juvenile sole (Solea solea).
Cocci P; Mosconi G; Palermo FA
Chemosphere; 2013 Oct; 93(6):1176-81. PubMed ID: 23866175
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil.
Shi C; Min L; Yang J; Dai M; Song D; Hua H; Xu G; Gonzalez FJ; Liu A
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):169-174. PubMed ID: 28374976
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR.
Aouabdi S; Gibson G; Plant N
Drug Metab Dispos; 2006 Jan; 34(1):138-44. PubMed ID: 16243957
[TBL] [Abstract][Full Text] [Related]
16. PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo.
Klein K; Thomas M; Winter S; Nussler AK; Niemi M; Schwab M; Zanger UM
Clin Pharmacol Ther; 2012 Jun; 91(6):1044-52. PubMed ID: 22510778
[TBL] [Abstract][Full Text] [Related]
17. Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes.
Roth A; Looser R; Kaufmann M; Meyer UA
Pharmacogenet Genomics; 2008 Apr; 18(4):325-37. PubMed ID: 18334917
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
Szalowska E; Tesfay HA; van Hijum SA; Kersten S
BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
